Suppr超能文献

卡马西平栓剂在大鼠体内的药学评价

Pharmaceutical evaluation of carbamazepine suppositories in rats.

作者信息

Shinoda M, Akita M, Hasegawa M, Nadai M, Hasegawa T, Nabeshima T

机构信息

Department of Hospital Pharmacy, Nagoya University Branch Hospital, Japan.

出版信息

Biol Pharm Bull. 1995 Sep;18(9):1289-91. doi: 10.1248/bpb.18.1289.

Abstract

The absorption of carbamazepine (CBZ) after rectal administration in the form of a suppository was studied in rats. CBZ suppositories were prepared with Witepsol H-15 (H-15), Witepsol S-55 (S-55) or polyethylene glycol 6000 (PEG) bases by moulding procedure. An in vitro investigation was undertaken using a dissolution apparatus. The in vitro dissolution rate of CBZ showed marked differences among the bases in the order PEG > H-15 > S-55. An in vivo study demonstrated marked differences in the time required to reach peak plasma concentration (Tmax) of CBZ after rectal and oral administration: the absorption of CBZ from PEG base was the most prolonged among these bases (in the order PEG > H-15 > S-55 > ORAL). Comparison of the area under the plasma concentration-time curve (AUC) of CBZ after rectal administration of the three different suppositories with those after intravenous and oral administration showed no significant differences in the AUC among the five preparations. These results suggest the possibility that CBZ suppositories can replace oral treatment for epilepsy.

摘要

在大鼠中研究了以栓剂形式直肠给药后卡马西平(CBZ)的吸收情况。采用模制工艺,用Witepsol H - 15(H - 15)、Witepsol S - 55(S - 55)或聚乙二醇6000(PEG)基质制备了CBZ栓剂。使用溶出装置进行了体外研究。CBZ的体外溶出速率在不同基质之间显示出显著差异,顺序为PEG>H - 15>S - 55。体内研究表明,直肠给药和口服给药后达到CBZ血浆浓度峰值(Tmax)所需的时间存在显著差异:在这些基质中,PEG基质中CBZ的吸收时间最长(顺序为PEG>H - 15>S - 55>口服)。将三种不同栓剂直肠给药后CBZ的血浆浓度 - 时间曲线下面积(AUC)与静脉注射和口服给药后的AUC进行比较,结果显示五种制剂的AUC之间无显著差异。这些结果提示CBZ栓剂有可能替代癫痫的口服治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验